We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
136 hedge funds and large institutions have $1.64B invested in Lexicon Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 43 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
12% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 43
10% more call options, than puts
Call options by funds: $5.09M | Put options by funds: $4.61M
7% more capital invested
Capital invested by funds: $1.53B → $1.64B (+$107M)
3.13% more ownership
Funds ownership: 106.32% → 109.45% (+3.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 23
6% less funds holding
Funds holding: 145 → 136 (-9)
Holders
136
Holders Change
-9
Holders Change %
-6.21%
% of All Funds
3.39%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
21
Increased
48
Reduced
43
Closed
23
Calls
$5.09M
Puts
$4.61M
Net Calls
+$481K
Net Calls Change
-$4.93M
Top Buyers
| 1 |
BlackRock
New York
|
+$71.8M |
| 2 |
CLM
ClearBridge LLC (Maryland)
Baltimore,
Maryland
|
+$10.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.68M |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$8.08M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$7.64M |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.98M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$1.81M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$1.67M |
| 4 |
Citigroup
New York
|
-$1.62M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.22M |
